Hepatocyte nuclear factor 1β suppresses canonical Wnt signaling through transcriptional repression of lymphoid enhancer-binding factor 1

被引:5
|
作者
Chan, Siu Chiu [1 ]
Hajarnis, Sachin S. [2 ,3 ]
Vrba, Sophia M. [1 ,4 ]
Patel, Vishal [2 ]
Igarashi, Peter [1 ,2 ]
机构
[1] Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA
[2] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA
[3] Otsuka Pharmaceut Dev & Commercializat Inc, Princeton, NJ USA
[4] NIAID, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
HNF-1β β -catenin; LEF1; kidney; histone methylation; tissue-specific transcription factor; Wnt pathway; beta-catenin (B-catenin); transcription repressor; T-cell factor (TCF); cystic kidney disease; WNT/BETA-CATENIN; KIDNEY DEVELOPMENT; GENE-EXPRESSION; RENAL CYSTS; FACTOR-I; HNF-1-BETA; ACTIVATION; DISEASE; MECHANISMS; COMPONENTS;
D O I
10.1074/jbc.RA120.015592
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hepatocyte nuclear factor-1 beta (HNF-1 beta) is a tissue-specific transcription factor that is required for normal kidney development and renal epithelial differentiation. Mutations of HNF-1 beta produce congenital kidney abnormalities and inherited renal tubulopathies. Here, we show that ablation of HNF-1 beta in mIMCD3 renal epithelial cells results in activation of beta-catenin and increased expression of lymphoid enhancer-binding factor 1 (LEF1), a downstream effector in the canonical Wnt signaling pathway. Increased expression and nuclear localization of LEF1 are also observed in cystic kidneys from Hnf1b mutant mice. Expression of dominant-negative mutant HNF-1 beta in mIMCD3 cells produces hyperresponsiveness to exogenous Wnt ligands, which is inhibited by siRNA-mediated knockdown of Lef1. WT HNF-1 beta binds to two evolutionarily conserved sites located 94 and 30 kb from the mouse Lef1 promoter. Ablation of HNF-1 beta decreases H3K27 trimethylation repressive marks and increases beta-catenin occupancy at a site 4 kb upstream to Lef1. Mechanistically, WT HNF-1 beta recruits the polycomb-repressive complex 2 that catalyzes H3K27 trimethylation. Deletion of the beta-catenin-binding domain of LEF1 in HNF-1 beta-deficient cells abolishes the increase in Lef1 transcription and decreases the expression of downstream Wnt target genes. The canonical Wnt target gene, Axin2, is also a direct transcriptional target of HNF-1 beta through binding to negative regulatory elements in the gene promoter. These findings demonstrate that HNF-1 beta regulates canonical Wnt target genes through long-range effects on histone methylation at Wnt enhancers and reveal a new mode of active transcriptional repression by HNF-1 beta.
引用
收藏
页码:17560 / 17572
页数:13
相关论文
共 50 条
  • [21] Evidence for association of lymphoid enhancer-binding factor-1 (LEF1) with the number of functional and inverted teats in pigs
    Tetzlaff, S.
    Jonas, E.
    Phatsara, C.
    Murani, E.
    Ponsuksili, S.
    Schellander, K.
    Wimmers, K.
    CYTOGENETIC AND GENOME RESEARCH, 2009, 124 (02) : 139 - 146
  • [22] Role of hepatitis B surface antigen in the development of hepatocellular carcinoma: regulation of lymphoid enhancer-binding factor 1
    Xiaochen Tian
    Jinjun Li
    Zhang-Mei Ma
    Chao Zhao
    Da-Fang Wan
    Yu-Mei Wen
    Journal of Experimental & Clinical Cancer Research, 28
  • [23] Role of hepatitis B surface antigen in the development of hepatocellular carcinoma: regulation of lymphoid enhancer-binding factor 1
    Tian, Xiaochen
    Li, Jinjun
    Ma, Zhang-Mei
    Zhao, Chao
    Wan, Da-Fang
    Wen, Yu-Mei
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2009, 28
  • [24] Transcriptional regulation of human CYP3A4 basal expression by CCAAT enhancer-binding protein α and hepatocyte nuclear factor-3γ
    Rodríguez-Antona, C
    Bort, R
    Jover, R
    Tindberg, N
    Ingelman-Sundberg, M
    Gómez-Lechón, MJ
    Castell, JV
    MOLECULAR PHARMACOLOGY, 2003, 63 (05) : 1180 - 1189
  • [25] Lymphoid enhancer-binding factor (LEF)l delays osteoblast differentiation.
    Kahler, RA
    Westendorf, JJ
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S304 - S304
  • [26] PRELIMINARY NMR INVESTIGATION OF THE HMG DOMAIN FROM THE LYMPHOID ENHANCER-BINDING FACTOR
    LOVE, JJ
    LI, X
    WRIGHT, PE
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 61 - 61
  • [27] Identification of the transcriptional repression domain of nuclear factor 1-A
    Osada, S
    Ikeda, T
    Xu, MX
    Nishihara, T
    Imagawa, M
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 238 (03) : 744 - 747
  • [28] Nuclear Factor κB Up-Regulation of CCAAT/Enhancer-Binding Protein β Mediates Hepatocyte Resistance to Tumor Necrosis Factor α Toxicity
    Wang, Yongjun
    Singh, Rajat
    Xiang, Youqing
    Greenbaum, Linda E.
    Czaja, Mark J.
    HEPATOLOGY, 2010, 52 (06) : 2118 - 2126
  • [29] High expression of lymphoid enhancer-binding factor-1 (LEF1) is a novel favorable prognostic factor in cytogenetically normal acute myeloid leukemia
    Metzeler, Klaus H.
    Heilmeier, Bernhard
    Edmaier, Katrin E.
    Rawat, Vijay P. S.
    Dufour, Annika
    Doehner, Konstanze
    Feuring-Buske, Michaela
    Braess, Jan
    Spiekermann, Karsten
    Buechner, Thomas
    Sauerland, Maria C.
    Doehner, Hartmut
    Hiddemann, Wolfgang
    Bohlander, Stefan K.
    Schlenk, Richard F.
    Bullinger, Lars
    Buske, Christian
    BLOOD, 2012, 120 (10) : 2118 - 2126
  • [30] Repression of transcriptional enhancer factor-1 and activator protein-1-dependent enhancer activity by vascular actin single-stranded DNA binding factor 2
    Kelm, RJ
    Sun, S
    Strauch, AR
    Getz, MJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (39) : 24278 - 24285